- Derm Potpourri10:42Paper Chase 1 - HPV Vaccine4:56Prostate 2.018:19Paper Chase 2 - Trial of Pregabalin for Acute and Chronic Sciatica4:43HPV Vaccination9:56Ondansetron: Autobot or Decepticon?13:54Paper Chase 3 - Clinicians' Expectations of Benefits & Harms6:06Multiple SclerosisFree Chapter25:33Social Determinants of Health: Poverty17:29Preeclampsia16:53Paper Chase 4 - Testosterone Treatment & Coronary Plaque3:47Atrial Fibrillation10:50Things I Do, But Should I? Wound Repair9:25Paper Chase 5 - Costs of Misdiagnosed Cellulitis6:18The Summary14:24
Andrew and Jake give us an update on all that’s new in the land of HPV vaccination. Makers of the mono and quadri-valent will be shortly withdrawing them from the market, leaving the nine-valent vaccine as the only option. Increased valency means broader coverage for wart and cervical causing strains of HPV. Lastly, recent data shows that two doses of vaccine is equivalent to 3 dose.